Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension

Journal of Molecular Neuroscience

Volumn 26, Issue 2-3, 2005, Pages 185-192

  AbdAlla, Said ^a,b   Abdel Baset, Ahmed ^b   Lother, Heinz ^a   El Massiery, Adel ^b   Quitterer, Ursula ^c  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b AIN SHAMS UNIVERSITY   (Egypt)

^c Institut für Pharmakologie   (Germany)

Author keywords

Angiotensin II; AT1 receptor; B2 receptor; Bradykinin; Dimerization; Essential hypertension; G protein coupled receptor; Kidney; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; BRADYKININ B2 RECEPTOR; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; RECEPTOR ANTIBODY; RECEPTOR SUBTYPE; ANGIOTENSIN II;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; CONFERENCE PAPER; CONTROLLED STUDY; DIMERIZATION; ESSENTIAL HYPERTENSION; EXPERIMENTAL MODEL; IMMUNOBLOTTING; KIDNEY; MALE; MESANGIUM CELL; NONHUMAN; PROTEIN SECRETION; RAT; RECEPTOR SENSITIVITY; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; DRUG EFFECT; MESANGIUM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DIMERIZATION; GLOMERULAR MESANGIUM; KIDNEY; MALE; RATS; RATS, INBRED SHR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, BRADYKININ B2; SIGNAL TRANSDUCTION;

EID: 25844505574     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:26:2-3:185     Document Type: Conference Paper

References (23)

1. 1 receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature 407, 94-98.
2. 1 receptor antagonist. J. Biol. Chem. 276, 39721-39726.
3. 1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat. Med. 7, 1003-1009.
4. Agnati L. F., Ferre S., Lluis C., Franco R., and Fuxe K. (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550.
5. 2 receptor knockout mice. Biochem. Biophys. Res. Commun. 224, 625-630.
6. Allen T. J., Cao Z., Youssef S., Hulthen U. L., and Cooper M. E. (1997) Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies. Diabetes 46, 1612-1618.
7. Beenen O. H., Mathy M. J., Pfaffendorf M., and van Zwieten P. A. (1996) Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J. Hypertens. 14, 1125-1130.
8. Collis M. G. and Vanhoutte P. M. (1978) Increased renal vascular reactivity to angiotensin II but not to nerve stimulation or exogenous norepinephrine in renal hypertensive rats. Circ. Res. 43, 544-552.
9. Correa F. M. A., Viswanathan M., Ciuffo G. M., Tsutsumi K., and Saavedra J. M. (1995) Kidney angiotensin II receptors and converting enzyme in neonatal and adult Wistar-Kyoto and spontanously hypertensive rats. Peptides 16, 19-24.
10. Fotiadis D., Liang Y., Filipek S., Saperstein D. A., Engel A., and Palczewski K. (2004) The G protein-coupled receptor rhodopsin in the native membrane. FEBS Lett. 564, 281-288.
11. Ikeda M., Kohno M., and Takeda T. (1995) Endothelin production in cultured mesangial cells of spontaneously hypertensive rats. Hypertension 25, 1196-1201.
12. Jacobi J., Schlaich M. P., Delles C., Schobel H. P., and Schmieder R. E. (1999) Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure. Am. J. Hypertens. 12, 418-422.
13. Kost C. K., Li P., Williams D. S., and Jackson E. K. (1998) Renal vascular responses to angiotensin II in conscious spontaneously hypertensive and normotensive rats. J. Cardiovasc. Pharmacol. 31, 854-861.
14. Lassila M., Finckenberg P., Pere A. K., Krogerus L., Ahonen J., Vapaatalo H., and Nurminen M. L. (2000) Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. Br. J. Pharmacol. 130, 1339-1347.
15. Ljungman S., Aurell M., Hartford M., Wikstrand J., and Berglund G. (1983) Effects of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 5, 368-374.
16. Plante G. E., Bissonnette M., Sirois M. G., Regoli D., and Sirois P. (1992) Renal permeability alteration precedes hypertension and involves bradykinin in the spontaneously hypertensive rat. J. Clin. Invest. 89, 2030-2032.
17. 1 receptor heterodimers and angiotensin II responsiveness in preeclampsia. Semin. Nephrol. 24, 115-119.
18. Song Q., Wang D. Z., Harley R. A., Chao L., and Chao J. (1996) Cellular localization of low-molecular-weight kininogen and bradykinin B2 receptor mRNAs in human kidney. Am. J. Physiol. 270, F919-F926.
19. Sorokin A. and Kohan D. E. (2003) Physiology and pathology of endothelin-1 in renal mesangium. Am. J. Physiol. Renal Physiol. 285, F579-F589.
20. Terrillon S. and Bouvier M. (2004) Roles of G-protein-coupled receptor dimerization. EMBO Rep. 5, 30-34.
21. Webb R. C., Johnson J. C., Vander A. J., and Henry J. P. (1983) Increased vascular sensitivity to angiotensin II in psychosocial hypertensive mice. Hypertension 5, 1165-1169.
22. Widgren B. R., Herlitz H., Aurell M., Berglund G., Wikstrand J., and Andersson O. K. (1992) Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am. J. Hypertens. 5, 167-174.
23. Zoja C., Donadelli R., Corna D., Testa D., Facchinetti D., Maffi R. et al. (1997) The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membraneous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist. Am. J. Kidney Dis. 29, 254-264.